These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1742755)

  • 1. Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses.
    Bleck TP; Jacobsen J
    Clin Neuropharmacol; 1991 Oct; 14(5):457-62. PubMed ID: 1742755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.
    Qweider M; Gilsbach JM; Rohde V
    J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal myeloencephalopathy due to intrathecal vincristine administration.
    al Fawaz IM
    Ann Trop Paediatr; 1992; 12(3):339-42. PubMed ID: 1280054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature.
    Pongudom S; Chinthammitr Y
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S258-63. PubMed ID: 21721457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.
    Alcaraz A; Rey C; Concha A; Medina A
    J Toxicol Clin Toxicol; 2002; 40(5):557-61. PubMed ID: 12215050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatality resulting from intraventricular vincristine administration.
    Meggs WJ; Hoffman RS
    J Toxicol Clin Toxicol; 1998; 36(3):243-6. PubMed ID: 9656982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection.
    Al Ferayan A; Russell NA; Al Wohaibi M; Awada A; Scherman B
    Childs Nerv Syst; 1999 Mar; 15(2-3):87-9. PubMed ID: 10230662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error.
    Williams ME; Walker AN; Bracikowski JP; Garner L; Wilson KD; Carpenter JT
    Cancer; 1983 Jun; 51(11):2041-7. PubMed ID: 6573227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine overdose: experience with 3 patients.
    Kosmidis HV; Bouhoutsou DO; Varvoutsi MC; Papadatos J; Stefanidis CG; Vlachos P; Scardoutsou A; Kostakis A
    Pediatr Hematol Oncol; 1991; 8(2):171-8. PubMed ID: 1863543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention.
    Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S
    J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural toxicity induced by accidental intrathecal vincristine administration.
    Kwack EK; Kim DJ; Park TI; Cho KR; Kwon IH; Sohn YK
    J Korean Med Sci; 1999 Dec; 14(6):688-92. PubMed ID: 10642952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
    Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
    Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accidental intraventricular vincristine administration: an avoidable iatrogenic death.
    Lau G
    Med Sci Law; 1996 Jul; 36(3):263-5. PubMed ID: 8918096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadvertent intramuscular administration of vincristine: lack of untoward effects without any treatment except administration of hot compresses.
    Olcay L; Safak T
    Pediatr Hematol Oncol; 2003; 20(5):427-8. PubMed ID: 12775543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Fatal Cases of Accidental Intrathecal Vincristine Administration: Learning from Death Events.
    Chotsampancharoen T; Sripornsawan P; Wongchanchailert M
    Chemotherapy; 2016; 61(2):108-10. PubMed ID: 26636546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
    Walter AW
    J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal myeloencephalopathy caused by intrathecal vincristine.
    Slyter H; Liwnicz B; Herrick MK; Mason R
    Neurology; 1980 Aug; 30(8):867-71. PubMed ID: 6893362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute encephalopathy following inadvertent intrathecal doxorubicin administration.
    Aricó M; Nespoli L; Porta F; Caselli D; Raiteri E; Burgio GR
    Med Pediatr Oncol; 1990; 18(3):261-3. PubMed ID: 2329972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing vincristine administration errors: Does evidence support minibag infusions?
    Schulmeister L
    Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the origin of EEG-slowing and encephalopathy during induction treatment of acute lymphoblastic leukemia.
    Korinthenberg R; Scheuring B; Boos J; Niemeyer C
    Med Pediatr Oncol; 2002 Dec; 39(6):566-72. PubMed ID: 12376979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.